ClinicalTrials.gg
Not yet recruitingNCT06743451Updated Dec 19, 2024

Enhancing Growth Monitoring Visits in Joshipur Rural Municipality, Kailai, Nepal

An interventional study of Health workers training on GMP guideline and Female community health volunteers' mobilization for inviting mothers and caretakers in Malnourished Children, sponsored by Kathmandu University School of Medical Sciences. Not yet recruiting at 1 site in Nepal. Per ClinicalTrials.gov, last updated 2024-12-19.

Sponsored by Kathmandu University School of Medical Sciences · Not applicable, Interventional, and Screening

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Not applicable
Sex
All
01

Study summary

The goal of this clinical trial is to learn if health workers training on growth promotion and monitoring guideline and Female Community Health Volunteers mobilization for increasing demand for growth monitoring and promotion, GMP through growth monitoring and promotion day, GMP day) can enhance the growth monitoring and promotion practices in mothers and caretaker having under two years children. The main questions it aims to answer are:

  • Does health workers training on GMP guideline enhances the growth monitoring and promotion practices in mothers and caretakers having under two years children?
  • Does FCHV mobilization enhances growth monitoring and promotion practices in mothers and caretakers having under two years children? Participants will
  • Health workers of the Joshipur rural municipality will have to attend Training session on GMP guideline,
  • Mothers and caretakers having under two years children will have to visit to the nearest health facility for GMP visits for their children
Read the detailed description

For addressing the problem of malnutrition in the municipality, determinants of the problem have been identified through CFIR framework. Based on the identified facilitator and barriers, two strategies have been developed for solving the problem of the municipality- (a) health workers training on latest GMP guideline to update the knowledge and skills of the service providers (b) For increasing demand generation, inviting mothers and caretakers having under two years children

  1. Health workers Training on GMP guideline: Mr. Ashish Timalsina will be responsible for one day training on GMP guideline to the health workers of all six health facilities who are primarily engaged in nutrition in Joshipur rural municipality.
  2. FCHV mobilization for increasing demand of growth monitoring and promotion through GMP day: Particular days of the month will be specified as GMP day in the municipality. Mothers and caretakers having under two years children. Health coordinator of the Joshipur rural municipality will be responsible for monitoring and supervision of this strategy.

Objectives General Objective

● To assess the implementation outcomes of Health workers Training on GMP guidelines and FCHV mobilization for increasing demand of Growth monitoring and Promotion through GMP day.

Specific Objectives

  • To assess acceptability, appropriateness, feasibility, fidelity of (a) Health workers Training on GMP guideline; and acceptability, appropriateness, feasibility of (b)FCHV mobilization for increasing demand of Growth monitoring and Promotion through GMP day by using PROCTOR's framework.
  • To assess the effectiveness of interventions- Health workers Training on GMP guideline and FCHV mobilization for increasing demand of Growth monitoring and Promotion through GMP day by average number of GMP visits.

    1. Methodology

Study site and its justification:

The study site will be Joshipur rural municipality, Kailali. There are seven wards in Joshipur Rural Municipality, in which a total of six health facilities are providing services in the Municipality. Average growth monitoring visit of the municipality was only 8 visits per child out of 24 visits per child (who have completed two years) in the fiscal year 2079/80 BS (2022 AD). The practice of growth monitoring was only 43% in the fiscal year 2079/80 BS (2022 AD). (HMIS)

02

Conditions studied

  • Malnourished Children

Browse trials for

Keywords

  • Nepal
  • Growth monitoring and Promotion
  • Malnutrition
03

In context

Malnutrition

1,277 studies on the registry are indexed under Malnutrition; 230 are open to participants now.

This study's planned enrollment of 80 is below the median of 118 across 843 interventional studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

Kathmandu University School of Medical Sciences is the lead sponsor of 26 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For Health Workers:

  1. Nutrition focal person of the health facility having primary engagement in growth monitoring and promotion.
  2. Trained on growth monitoring and promotion guideline.

For Female Community Health Volunteers 1. Active for inviting mothers and caretakers of the municipality

For Mothers and caretakers having under two years children

  1. Any mothers and caretakers having under two years children residing in Joshipur Rural Municipality during intervention.

Exclusion criteria

Exclusion Criteria:

Who not available during the time of data collection

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Health workers of Joshipur rural municipality and Female community health volunteers

    Health workers will receive Training on GMP guideline, while FCHV will be mobilized for inviting mothers and caretakers having under two years children.

    Other: Health workers training on GMP guideline · Other: Female community health volunteers' mobilization for inviting mothers and caretakers

Interventions

  • OtherHealth workers training on GMP guideline

    One day training will be conducted to health workers on updated GMP guideline for the health workers primarily engaged in Growth monitoring and promotion of the children.

  • OtherFemale community health volunteers' mobilization for inviting mothers and caretakers

    Female community health volunteers will be mobilized for inviting mothers and caretakers for two consecutive months for enhancing GMP practices in the municipality

06

What researchers measure

Primary outcomes

  1. Acceptability of Health Workers Training using key informant interview

    Acceptability includes the attitude and perception of health workers regarding Health workers training and satisfaction level of health workers attending Health workers training on GMP guidelines. For which, a qualitative method (KII) with health workers using KII guideline will be employed for information collection among the health workers attending the health worker's Training

    Time frame: At three months

  2. Appropriateness of Health workers Training using Key informant interview

    Appropriateness is defined as Health workers training suitable for the cultural, social and economic context of Joshipur rural municipality and alignment of Health workers training to the needs and preferences of the health workers. For which, Key Informant Interview using KII guideline will be employed for information collection

    Time frame: At three months

  3. Feasibility of Health workers Training

    Feasibility includes practicality and ease of attending health workers training and availability of resources. For which information will be collected from health workers through Key Informant Interview using KII guideline.

    Time frame: At three months

  4. Fidelity to GMP steps assed through observing HMIS register

    Fidelity to GMP steps refers to evaluating the extent to which health workers adhere to the steps of GMP. It will be assessed by observing at the nutrition register by health workers as recoded of the steps conducted for growth monitoring and Promotion.

    Time frame: At three months

  5. Acceptability of GMP day

    Acceptability includes the attitude and perception of mothers and caretakers regarding Growth monitoring and Promotion Day . For which, qualitative method (Focus group discussion, FGD using FGD guideline, In-depth Interview, IDI using IDI guideline) will be employed for information collection.

    Time frame: At three months

  6. Appropriateness of GMP day

    Appropriateness includes the alignment of the Growth monitoring and Promotion Day with the needs and preferences of the target population. For which Qualitative method will be employed for information collection.

    Time frame: At three months

  7. Feasibility of GMP day to health workers using key informant interview

    Feasibility includes practicality and ease of implementing GMP day from health workers in the health facility which will be assessed using Key informant interview with health workers using KII guideline.

    Time frame: At three months

07

Study locations

1 site
  • Joshipur rural Municipality
    Joshipur, Far western 10909, Nepal
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2024; primary completion for Aug 2025, 8 months later.

Of 392 non-industry interventional studies with no phase under Malnutrition, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 8 months is below that.

Counting every sponsor, half of 418 studies reached it within 22 months; a quarter within 11 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 10, 2024
First posted
Dec 19, 2024
StartEst.
Dec 2024
Primary completionEst.
Aug 2025
CompletionEst.
Aug 2025
Last update
Dec 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06743451
Lead sponsor
Kathmandu University School of Medical Sciences
Responsible party
Amrita Ghimire (Lecturer (Public Health), Kathmandu University School of Medical Sciences) — Principal investigator
First posted
Dec 19, 2024
Start date
Dec 2024 (estimated)
Primary completion
Aug 2025 (estimated)
Completion
Aug 2025 (estimated)
Last update
Dec 19, 2024

Study contacts

Amrita Ghimire, MPH
Contact
ghimireamrita@gmail.com
+977-9851188538
Asish Timalsina, MPH
Contact
ashish.timalsina@gmail.com
+977-9843523211
Amrita Ghimire, MPH
principal investigator · Kathmandu University School of Medical Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion